Like so many romances, the impending $277 million marriage between Accuray Inc. (NSDQ:ARAY) and TomoTherapy Inc. (NSDQ:TOMO) began on the shores of the Mediterranean, in the beautiful city of Barcelona.
Mergers & Acquisitions
Thermo Fisher extends Dionex merger offer again
The marriage of Thermo Fisher Scientific Inc. (NYSE:TMO) and Dionex Corp. (NSDQ:DNEX) will have to wait another month to be fully consummated.
Thermo Fisher officials released a statement today saying the deadline for the $2.2 billion deal would be pushed back to May 13 to satisfy the remaining anti-trust hurdles in the European Union.
Pfizer offloads Capsugel to KKR for $2.4 billion
Health IT firm CSC to buy iSoft | Acquisitions roundup
Accuray/Tomotherapy merger: Did the fish swallow the whale?
Quest’s $740 million Athena buyout gets FTC go-ahead | Acquisitions roundup
The Federal Trade Commission approved Quest Diagnostics Inc.’s (NYSE:DGX) $740 million cash purchase of Athena Diagnostics Inc. from Thermo Fisher Scientific Inc. (NYSE:TMO).
Madison, N.J.-based Quest won an early termination of the premerger review from the FTC, bringing the company another step closer to acquiring the Worcester, Mass.-based laboratory, which specializes in genetic testing for neurological disorders.
GOP targets AARP over health care law
Republicans in the U.S. House of Representatives are getting ready to use the bully pulpit against the AARP and its support of the health care reform law, calling the senior citizens group on the carpet for a close look at its finances.
A pair of the House Ways and Means Committee’s sub-panels are slated to grill AARP executives April 1 about how the association will benefit from the Patient Protection & Affordable Care Act via its endorsements of various insurance products.
Cleveland Clinic’s sale of spinoff Intelect Medical brings $28 million windfall
It’s no wonder that Cleveland Clinic has placed an increased emphasis on commercializing medical innovations by its doctors.
Cleveland Clinic CEO Toby Cosgrove revealed in a recent interview that the $78 million sale of Clinic neurotechnology spinoff Intelect Medical to Boston Scientific Corp. (NYSE:BSX) in January returned an impressive $28 million to the health system.
PerkinElmer drops $220 million on a pair of software companies
PerkinElmer Inc. (NYSE:PKI) made announcements on two software firm acquisition deals intended to expand its offerings for the pharmaceutical industry.
The Waltham, Mass.-based life science and health IT firm said it will spend about $220 million as it closed its deal on R&D software company ArtusLabs Inc. and announced an agreement to acquire CambridgeSoft Corp.
Theragenics turns down takeover proposal | Acquisitions roundup
Theragenics Corp. (NYSE:TGX) won’t go for a bargain price, company officials said last week.